QQQ   272.37 (+0.18%)
AAPL   141.13 (-0.95%)
MSFT   237.94 (+0.19%)
META   139.29 (+2.11%)
GOOGL   97.65 (+0.24%)
AMZN   115.58 (+0.68%)
TSLA   270.55 (+0.87%)
NVDA   124.82 (+2.14%)
NIO   15.99 (+2.63%)
BABA   81.18 (+2.68%)
AMD   64.66 (+0.81%)
T   15.48 (-0.32%)
MU   51.20 (+2.38%)
CGC   2.82 (+1.44%)
F   11.41 (-0.52%)
GE   62.68 (-0.08%)
DIS   96.72 (-0.75%)
AMC   7.26 (+2.25%)
PYPL   88.27 (-0.48%)
PFE   44.28 (+0.27%)
NFLX   239.68 (-0.01%)
QQQ   272.37 (+0.18%)
AAPL   141.13 (-0.95%)
MSFT   237.94 (+0.19%)
META   139.29 (+2.11%)
GOOGL   97.65 (+0.24%)
AMZN   115.58 (+0.68%)
TSLA   270.55 (+0.87%)
NVDA   124.82 (+2.14%)
NIO   15.99 (+2.63%)
BABA   81.18 (+2.68%)
AMD   64.66 (+0.81%)
T   15.48 (-0.32%)
MU   51.20 (+2.38%)
CGC   2.82 (+1.44%)
F   11.41 (-0.52%)
GE   62.68 (-0.08%)
DIS   96.72 (-0.75%)
AMC   7.26 (+2.25%)
PYPL   88.27 (-0.48%)
PFE   44.28 (+0.27%)
NFLX   239.68 (-0.01%)
QQQ   272.37 (+0.18%)
AAPL   141.13 (-0.95%)
MSFT   237.94 (+0.19%)
META   139.29 (+2.11%)
GOOGL   97.65 (+0.24%)
AMZN   115.58 (+0.68%)
TSLA   270.55 (+0.87%)
NVDA   124.82 (+2.14%)
NIO   15.99 (+2.63%)
BABA   81.18 (+2.68%)
AMD   64.66 (+0.81%)
T   15.48 (-0.32%)
MU   51.20 (+2.38%)
CGC   2.82 (+1.44%)
F   11.41 (-0.52%)
GE   62.68 (-0.08%)
DIS   96.72 (-0.75%)
AMC   7.26 (+2.25%)
PYPL   88.27 (-0.48%)
PFE   44.28 (+0.27%)
NFLX   239.68 (-0.01%)
QQQ   272.37 (+0.18%)
AAPL   141.13 (-0.95%)
MSFT   237.94 (+0.19%)
META   139.29 (+2.11%)
GOOGL   97.65 (+0.24%)
AMZN   115.58 (+0.68%)
TSLA   270.55 (+0.87%)
NVDA   124.82 (+2.14%)
NIO   15.99 (+2.63%)
BABA   81.18 (+2.68%)
AMD   64.66 (+0.81%)
T   15.48 (-0.32%)
MU   51.20 (+2.38%)
CGC   2.82 (+1.44%)
F   11.41 (-0.52%)
GE   62.68 (-0.08%)
DIS   96.72 (-0.75%)
AMC   7.26 (+2.25%)
PYPL   88.27 (-0.48%)
PFE   44.28 (+0.27%)
NFLX   239.68 (-0.01%)
NYSE:PRGO

Perrigo - PRGO Stock Forecast, Price & News

$36.22
+0.27 (+0.75%)
(As of 09/30/2022 11:55 AM ET)
Add
Compare
Today's Range
$35.96
$36.58
50-Day Range
$35.95
$42.98
52-Week Range
$31.32
$50.90
Volume
20,143 shs
Average Volume
1.01 million shs
Market Capitalization
$4.88 billion
P/E Ratio
N/A
Dividend Yield
2.84%
Price Target
$54.50

Perrigo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
43.7% Upside
$51.67 Price Target
Short Interest
Bearish
4.20% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.93
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
32.75%
From $2.29 to $3.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.77 out of 5 stars

Medical Sector

65th out of 1,097 stocks

Pharmaceutical Preparations Industry

19th out of 548 stocks

PRGO stock logo

About Perrigo (NYSE:PRGO) Stock

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Stock News Headlines

Perrigo Company PLC
Is Perrigo (PRGO) a Smart Investment Choice?
Perrigo Enters Oversold Territory
Perrigo (PRGO) Lags Q2 Earnings Estimates
See More Headlines
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Company Calendar

Last Earnings
8/09/2022
Ex-Dividend for 9/20 Dividend
9/01/2022
Dividend Payable
9/20/2022
Today
9/30/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
71429010
Employees
9,900
Year Founded
1887

Price Target and Rating

Average Stock Price Forecast
$51.67
High Stock Price Forecast
$55.00
Low Stock Price Forecast
$46.00
Forecasted Upside/Downside
+50.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-68,900,000.00
Pretax Margin
6.39%

Debt

Sales & Book Value

Annual Sales
$4.14 billion
Cash Flow
$4.33 per share
Book Value
$38.51 per share

Miscellaneous

Free Float
133,541,000
Market Cap
$4.88 billion
Optionable
Optionable
Beta
0.92

Social Links


Key Executives

  • Mr. Murray S. Kessler (Age 62)
    CEO, Pres & Director
    Comp: $2.78M
  • Mr. Svend  AndersenMr. Svend Andersen (Age 60)
    Exec. VP & Pres of Consumer Self-Care International
    Comp: $1.18M
  • Mr. James E. Dillard III (Age 58)
    Exec. VP & Pres of Consumer Self-Care Americas
    Comp: $999.36k
  • Mr. Eduardo Guarita Bezerra (Age 47)
    Exec. VP & CFO
  • Mr. Ronald C. JanishMr. Ronald C. Janish (Age 56)
    Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain
  • Mr. Shannon Hukill
    Sr. Director of Technical Operations
  • Mr. Thomas M. FarringtonMr. Thomas M. Farrington (Age 65)
    Chief Information Officer & Exec. VP
  • Ms. Alison Ives
    Exec. VP & Chief Scientific Officer
  • Mr. Bradley Joseph
    VP of Global Investor Relations & Corp. Communications
  • Ms. Kyle L. Hanson (Age 57)
    Exec. VP, Gen. Counsel & Corp. Sec.













PRGO Stock - Frequently Asked Questions

Should I buy or sell Perrigo stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PRGO shares.
View PRGO analyst ratings
or view top-rated stocks.

What is Perrigo's stock price forecast for 2022?

3 brokers have issued twelve-month target prices for Perrigo's stock. Their PRGO share price forecasts range from $46.00 to $55.00. On average, they expect the company's stock price to reach $51.67 in the next year. This suggests a possible upside of 43.2% from the stock's current price.
View analysts price targets for PRGO
or view top-rated stocks among Wall Street analysts.

How have PRGO shares performed in 2022?

Perrigo's stock was trading at $38.90 on January 1st, 2022. Since then, PRGO shares have decreased by 7.2% and is now trading at $36.08.
View the best growth stocks for 2022 here
.

When is Perrigo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our PRGO earnings forecast
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) posted its quarterly earnings data on Tuesday, August, 9th. The company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.44 by $0.01. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.06 billion. Perrigo had a positive trailing twelve-month return on equity of 4.87% and a negative net margin of 2.17%. Perrigo's quarterly revenue was up 14.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.50 EPS.
Read the conference call transcript
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Tuesday, August 2nd. Shareholders of record on Friday, September 2nd will be given a dividend of $0.26 per share on Tuesday, September 20th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Thursday, September 1st.
Read our dividend analysis for PRGO
.

Is Perrigo a good dividend stock?

Perrigo (NYSE:PRGO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 2.84%.
Read our dividend analysis for PRGO.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY 2022 earnings guidance on Tuesday, September, 13th. The company provided EPS guidance of $2.25-$2.35 for the period. The company issued revenue guidance of $4.49 billion-$4.53 billion, compared to the consensus revenue estimate of $4.49 billion.

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo Chief Executive Officer Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How do I buy shares of Perrigo?

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $36.08.

How much money does Perrigo make?

Perrigo (NYSE:PRGO) has a market capitalization of $4.86 billion and generates $4.14 billion in revenue each year. The company earns $-68,900,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

How many employees does Perrigo have?

The company employs 9,900 workers across the globe.

Does Perrigo have any subsidiaries?
The following companies are subsidiares of Perrigo: 010414 UK Limited, 251211 UK Limited, Abtei Omega Pharma GmbH, Aco Hud Nordic AB, Adriatic BST Trgovina in Storitve D.o.o., Adriatic Distribution doo Beograd, Agis Industries, Algorithmics Risk Management Limited, Arginet Investments and Property (2003) Ltd., Athena Neurosciences LLC, Aurora Pharmaceuticals Pty Ltd, Biover NV, Blue Wolf Global Limited, Bluewolf International Limited, Brunel Healthcare Manufacturing Limited, CP Kayak Holdings Inc., CanNegev Ltd, Chefaro Ireland Designated Activity Company, Cinetic Laboratories Argentina SA, Cleversafe UK Limited, Cosmediet - Biotechnie SAS, Despharma Kft., Elan Corporation, Elan Europa Finance S.á r.l., Elan International Services Limited, Elan Pharmaceuticals LLC, Fera Pharmaceuticals, Galpharm Healthcare Limited, Galpharm International, Galpharm International Limited, Geiss Destin & Dunn, Gelcaps Exportadora de Mexico S.A. de C.V., Gr8ness LLC, HRA Pharma, Habsont Unlimited Company, Heartbeat Experts Limited, IBM GF international Treasury Company, IBM International Treasury Services Unlimited Company, IBM Netherlands Treasury B.V., Interdelta S.A., International Business Machines Limited, Irish Biosciences Venture Capital Fund, JB Laboratories, JLR Pharma S.A., Jaico R.D.P. NV, Jewel Consumer Care Pvt. Ltd., Kazmira LLC, Kenexa Global Recruitment Services Limited, Kenexa Quorum Holdings Limited, Kenexa Technology LLC, Kiteacre Limited, L. Perrigo Company, Laboratoire de la Mer SAS, Laboratoires Omega Pharma France SAS, Laboratorios DIBA S.A., Laboratorios Diba, Luxembourg Investment Company 289 Sàrl, MH (UK) Limited, Medgenix Benelux NV, Monksland Holdings B.V., Naturwohl Pharma GmbH, ORION Laboratories, Oce Bio BV, Oce-Bio Nederland B.V., Omega Alpharm Cyprus Ltd., Omega Pharma, Omega Pharma AS, Omega Pharma Australia Pty Ltd, Omega Pharma Austria Healthcare GmbH, Omega Pharma Baltics SIA, Omega Pharma Belgium NV, Omega Pharma Capital NV, Omega Pharma Deutschland GmbH, Omega Pharma GmbH, Omega Pharma Hellas SA Health and Beauty Products, Omega Pharma Hungary Kft., Omega Pharma Innovation & Development NV, Omega Pharma International NV, Omega Pharma Limited, Omega Pharma Luxembourg SarL, Omega Pharma Manufacturing GmbH & Co. KG, Omega Pharma Manufacturing Verwaltungs GmbH, Omega Pharma Nederland B.V., Omega Pharma Trading NV, Omega Pharma s.r.o., Omega Teknika Designated Activity Company, OmegaLabs (Pty) Ltd, Oniqua Europe Limited, Optevia Limited, Orion Laboratories (NZ) Ltd., Orion Laboratories PTY Limited, P-Direct NL B.V., P2C Inc., PBM Canada Holdings LLC, PBM China Holdings LLC, PBM Foods LLC, PBM Holdings LLC, PBM International Holdings LLC, PBM Mexico Holdings LLC, PBM Nutritionals LLC, PBM Products, PBM Products LLC, PBM Products Mexico S de R.L. de C.V., PMI Branded Pharmaceuticals Inc., Paddock Laboratories, Paracelsia Pharma GmbH, Perrigo Asia Holding Company Ltd., Perrigo Australian Holding Company II PTY Limited, Perrigo Bulgaria OOD, Perrigo China Business Trust, Perrigo China Business Trustee LLC, Perrigo Company, Perrigo Company Charitable Foundation, Perrigo Company of Tennessee, Perrigo Company plc, Perrigo Corporation Designated Activity Company, Perrigo Danmark A/S, Perrigo Diabetes Care LLC, Perrigo Direct Inc., Perrigo España SA, Perrigo Europe Invest NV, Perrigo Finance (US) LLC, Perrigo Finance Unlimited Company, Perrigo Florida Inc., Perrigo France SAS, Perrigo Global Holdings Inc., Perrigo Holding NV, Perrigo Holdings Unlimited Company, Perrigo International Finance Designated Activity Company, Perrigo International Holdings II Inc., Perrigo International Holdings LLC, Perrigo International Inc., Perrigo International Insurance Limited, Perrigo Ireland 1 Designated Activity Company, Perrigo Ireland 10 Unlimited Company, Perrigo Ireland 11 DAC, Perrigo Ireland 12 Designated Activity Company, Perrigo Ireland 13 Designated Activity Company, Perrigo Ireland 2 Designated Activity Company, Perrigo Ireland 3 Designated Activity Company, Perrigo Ireland 4 Unlimited Company, Perrigo Ireland 5 Unlimited Company, Perrigo Ireland 6 Unlimited Company, Perrigo Ireland 7 Designated Activity Company, Perrigo Ireland 8 Designated Activity Company, Perrigo Ireland 9 Unlimited Company, Perrigo Ireland Holding Company B.V., Perrigo Ireland Management Designated Activity Company, Perrigo Israel Enterprises & Investments Ltd., Perrigo Israel Holdings II B.V., Perrigo Israel Opportunities II Ltd., Perrigo Israel Trading Limited Partnership, Perrigo Italia S.r.l, Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi, Perrigo LLC, Perrigo Laboratories India Private Limited, Perrigo Management Company, Perrigo Mexico Holding S.A. de C.V., Perrigo Mexico Investment Holdings LLC, Perrigo Netherlands B.V., Perrigo Netherlands Finco 1 Coöperatief U.A., Perrigo Netherlands Finco 2 B.V., Perrigo Netherlands International Partnership C.V., Perrigo New York Inc., Perrigo Norge AS, Perrigo Oral Health Care Holdings Inc., Perrigo Pharma Holding Nederland BV, Perrigo Pharma International Designated Activity Company, Perrigo Pharma Limited, Perrigo Poland Sp.z.o.o, Perrigo Portugal LDA, Perrigo Research & Development Company, Perrigo România S.R.L., Perrigo Sales Corporation, Perrigo Science Eight Unlimited Company, Perrigo Science One Designated Activity Company, Perrigo Suomi Oy, Perrigo Sverige AB, Perrigo Trading (Shanghai) Co. Ltd., Perrigo UK Acquisition Limited, Perrigo UK Finco Limited Partnership, Perrigo Ukraine LLC, Perrigo Ventures Limited Partnership, Perrigo de Mexico S.A. de C.V., Perrigo do Brasil Farmaceutica Ltda., Pharma Clal (1983) Ltd., Promontory Financial Group (UK) Limited, Quimica y Farmacia S.A. de C.V., Ranir, Ranir (Holdings) Limited, Ranir Changshu Oral Care CO. Ltd., Ranir Global Holdings LLC, Ranir LLC, Ranir Limited, Resilient Systems Europe Limited, Richard Bittner AG, Rosemont Pharmaceuticals, Rubicon Healthcare Holdings Pty Ltd, SPSS Limited, Samenwerkende Apothekers Nederland B.V., ScarAway, Silverpop Systems Limited, Simpler Consulting Limited, Solent Dental Company Limited, Solent Oral Care Limited, Sterling Commerce (UK) Limited, The Analytic Sciences Corporation Limited, The Learning Pharmacy Limited, The Weather Channel Global Media Limited, Totalcare International Corp, Transitive Corporation Limited, Transitive Limited, Truven Health Analytics UK Limited, Velcera, Weather Services International Limited, Wrafton Laboratories, Wrafton Laboratories Limited, Zibo Xinhua - Perrigo Pharmaceutical Company Ltd., i2 Holdings Limited, i2 Intermediate Holdings Limited, and i2 Limited.
Read More
How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The official website for the company is www.perrigo.com. The company can be reached via phone at (531) 709-4000, via email at bradley.joseph@perrigo.com, or via fax at 269-673-9128.

This page (NYSE:PRGO) was last updated on 9/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.